Pulmicort Formulations for Asthma Treatment
Pulmicort (budesonide) is available in two inhaled formulations for asthma: a nebulizer suspension (Pulmicort Respules) and a dry powder inhaler (Pulmicort Turbuhaler), with no oral or injectable forms approved for asthma treatment. 1, 2
Available Inhaled Formulations
Nebulizer Suspension (Pulmicort Respules)
- Strengths: 0.25 mg/2 mL and 0.5 mg/2 mL single-dose ampules 1, 2
- FDA-approved age: Children 12 months to 8 years 1
- Unique distinction: This is the only inhaled corticosteroid with FDA-approved labeling for children under 4 years of age 3
- Device requirement: Must be administered via jet nebulizer only—ultrasonic nebulizers are ineffective for suspensions 3, 4, 1
- Compatibility: Can be mixed with albuterol, ipratropium, and levalbuterol in the same nebulizer 3
Dry Powder Inhaler (Pulmicort Turbuhaler)
- Strengths: 90,180, or 200 mcg/inhalation 3
- Age indication: Patients ≥6 years 3
- Dosing ranges 3:
- Children 5-11 years: Low dose 180-400 mcg/day, medium >400-800 mcg/day, high >800 mcg/day
- Adults: Low dose 600 mcg/day, medium >600-1200 mcg/day, high >1200 mcg/day
Dosing Considerations
Nebulizer Suspension Dosing
The recommended starting doses based on previous therapy 1:
- Bronchodilators alone or inhaled corticosteroids: 0.5 mg once daily or 0.25 mg twice daily, up to 0.5 mg twice daily
- Oral corticosteroids: 0.5 mg twice daily
- Symptomatic children not responding to non-steroidal therapy: May start with 0.25 mg once daily
Critical implementation point: Once-daily dosing can be administered in either morning or evening with comparable efficacy 5. If once-daily treatment doesn't provide adequate control, increase total daily dose and/or divide into twice-daily administration 1.
Administration Technique
For children <4 years using nebulizer suspension 3:
- Requires face mask that fits snugly over nose and mouth
- Avoid nebulizing in the eyes
- Wash face after each treatment to prevent local corticosteroid side effects
- Use only jet nebulizers with 6-8 L/min flow rate 4
No Oral or Injectable Forms
There are no oral or injectable formulations of Pulmicort approved for asthma treatment. The evidence discusses oral corticosteroids like prednisolone for acute exacerbations 4, but these are different medications entirely. One study mentions a viscous oral budesonide preparation for eosinophilic esophagitis 6, but this is not an FDA-approved formulation for asthma and represents off-label use for a different condition.
Common Pitfalls to Avoid
- Device mismatch: Never use ultrasonic nebulizers with Respules—they are ineffective for suspensions 3, 4, 1
- Age-inappropriate prescribing: The Turbuhaler is not approved for children <6 years; use Respules instead 3
- Dosing confusion: Preparations are not interchangeable on a mcg-per-puff basis between devices 3
- Acute treatment error: Budesonide is for maintenance therapy only, not for relief of acute bronchospasm 1
Safety Profile
Long-term studies demonstrate budesonide is well-tolerated across age groups 7, 8, 9. At doses required for mild-to-moderate asthma, budesonide does not affect HPA axis function, bone mineral density, or final adult height 10. Budesonide (as Turbuhaler) is the only inhaled corticosteroid with FDA pregnancy category B rating 10.